Search research articles
Contact Us
Filters
Showing results (61-70 of 156) with videos related to
Page
of 16
Sort By:
Maturitas
|
April 9, 2021
Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerations
Stergios A Polyzos, Athanasios D Anastasilakis, Zoe A Efstathiadou, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 23, 2014
The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea
Joo-Pin Foo, Stergios A Polyzos, Athanasios D Anastasilakis, et al.
Journal of Clinical Medicine
|
September 28, 2023
Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of Denosumab
Athanasios D Anastasilakis, Polyzois Makras, Julien Paccou, et al.
Journal of Clinical Medicine
|
January 7, 2021
Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review
Athanasios D Anastasilakis, Polyzois Makras, Maria P Yavropoulou, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
June 10, 2010
A case report of subacute thyroiditis during pregnancy: difficulties in differential diagnosis and changes in cytokine levels
Athanasios D Anastasilakis, Vassiliki Karanicola, Anargyros Kourtis, et al.
Bone
|
June 14, 2020
The three-year effect of a single zoledronate infusion on bone mineral density and bone turnover markers following denosumab discontinuation in women with postmenopausal osteoporosis
Polyzois Makras, Socrates E Papapoulos, Stergios A Polyzos, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
February 5, 2021
Efficacy of Antiosteoporotic Medications in Patients With Rebound-Associated Fractures After Denosumab Discontinuation
Athanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 28, 2017
Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases
Athanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 22, 2019
Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial
Athanasios D Anastasilakis, Socrates E Papapoulos, Stergios A Polyzos, et al.
Clinical Endocrinology
|
October 17, 2009
The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis
Athanasios D Anastasilakis, Stergios A Polyzos, Avraam Avramidis, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 156) with videos related to
Sort By:
Page
of 16
Maturitas
|
April 9, 2021
Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerations
Stergios A Polyzos, Athanasios D Anastasilakis, Zoe A Efstathiadou, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 23, 2014
The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea
Joo-Pin Foo, Stergios A Polyzos, Athanasios D Anastasilakis, et al.
Journal of Clinical Medicine
|
September 28, 2023
Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of Denosumab
Athanasios D Anastasilakis, Polyzois Makras, Julien Paccou, et al.
Journal of Clinical Medicine
|
January 7, 2021
Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review
Athanasios D Anastasilakis, Polyzois Makras, Maria P Yavropoulou, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
June 10, 2010
A case report of subacute thyroiditis during pregnancy: difficulties in differential diagnosis and changes in cytokine levels
Athanasios D Anastasilakis, Vassiliki Karanicola, Anargyros Kourtis, et al.
Bone
|
June 14, 2020
The three-year effect of a single zoledronate infusion on bone mineral density and bone turnover markers following denosumab discontinuation in women with postmenopausal osteoporosis
Polyzois Makras, Socrates E Papapoulos, Stergios A Polyzos, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
February 5, 2021
Efficacy of Antiosteoporotic Medications in Patients With Rebound-Associated Fractures After Denosumab Discontinuation
Athanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 28, 2017
Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases
Athanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 22, 2019
Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial
Athanasios D Anastasilakis, Socrates E Papapoulos, Stergios A Polyzos, et al.
Clinical Endocrinology
|
October 17, 2009
The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis
Athanasios D Anastasilakis, Stergios A Polyzos, Avraam Avramidis, et al.
Page
of 16